Publications

Immunohistochemical Versus Molecular (Blueprint and Mammaprint) Subtyping of Breast Carcinoma. Outcome Results from the Eortc 10041/Big 3-04 Mindact Trial

AuthID
P-00N-1S9

Author(s)

Viale, G

de Snoo, FA

Slaets, L

Bogaerts, J

van 't Veer, L

Rutgers, EJ

Piccart Gebhart, MJ

Stork Sloots, L

Glas, A

Russo, L

Dell'Orto, P

Tryfonidis, K

Litiere, S

Cardoso, F

Group Author(s)

MINDACT Investigators

Document Type

Article

Year published

2018

Published

in BREAST CANCER RESEARCH AND TREATMENT, ISSN: 0167-6806

Volume: 167, Issue: 1, Pages: 123-131 (9)

Indexing

Wos^®

Scopus^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1007/s10549-017-4509-9

Scopus: 2-s2.0-85029575399

Wos: WOS:000423534700013

Source Identifiers

ISSN: 0167-6806

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Immunohistochemical Versus Molecular (Blueprint and Mammaprint) Subtyping of Breast Carcinoma. Outcome Results from the Eortc 10041/Big 3-04 Mindact Trial

Useful Links

Get Help

Federated Authentication (Click on the image)

Immunohistochemical Versus Molecular (Blueprint and Mammaprint) Subtyping of Breast Carcinoma. Outcome Results from the Eortc 10041/Big 3-04 Mindact Trial

Useful Links

Get Help